Table of Contents
ISRN Dermatology
Volume 2011 (2011), Article ID 848909, 8 pages
http://dx.doi.org/10.5402/2011/848909
Research Article

Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms

1Department of Quality Control, Center of Molecular Immunology, Havana 11600, Cuba
2Department of Pathology, Manuel Fajardo General Hospital, Havana 10400, Cuba
3Research and Development Direction, Center of Molecular Immunology, 216 Street, 15 Avenue, Atabey, Playa, P.O. Box 16040, Havana 11600, Cuba

Received 11 February 2011; Accepted 22 March 2011

Academic Editors: F. Fabrizio and D. Watanabe

Copyright © 2011 Rancés Blanco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun, “Cancer statistics, 2007,” Ca: A Cancer Journal for Clinicians, vol. 57, no. 1, pp. 43–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. R. Martinez, G. Francisco, L. S. Cabral, I. R. G. Ruiz, and C. F. Neto, “Molecular genetics of non-melanoma skin cancerGenética molecular aplicada ao câncer cutâneo não melanoma,” Anais Brasileiros de Dermatologia, vol. 81, no. 5, pp. 405–419, 2006. View at Google Scholar · View at Scopus
  3. C. M. Balch, J. E. Gershenwald, S. J. Soong et al., “Final version of 2009 AJCC melanoma staging and classification,” Journal of Clinical Oncology, vol. 27, no. 36, pp. 6199–6206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Yamashita, R. Wada, T. Sasaki et al., “A vital role for glycosphingolipid synthesis during development and differentiation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 16, pp. 9142–9147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Birklé, G. Zeng, L. Gao, R. K. Yu, and J. Aubry, “Role of tumor-associated gangliosides in cancer progression,” Biochimie, vol. 85, no. 3-4, pp. 455–463, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Higashi, T. Sasabe, Y. Fukui, M. Maru, and S. Kato, “Detection of gangliosides as N-glycolylneuraminic acid-specific tumor-associated Hanganutziu-Deicher antigen in human retinoblastoma cells,” Japanese Journal of Cancer Research, vol. 79, no. 8, pp. 952–956, 1988. View at Google Scholar · View at Scopus
  7. M. Miyake, K. Hashimoto, M. Ito et al., “The abnormal occurrence and the differentiation-dependent distribution of N-acetyl and N-glycolyl species of the ganglioside GM2 in human germ cell tumors. A study with specific monoclonal antibodies,” Cancer, vol. 65, no. 3, pp. 499–505, 1990. View at Google Scholar
  8. S. Watarai, Y. Kushi, R. Shigeto et al., “Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides,” Journal of Biochemistry, vol. 117, no. 5, pp. 1062–1069, 1995. View at Google Scholar · View at Scopus
  9. S. Zhang, C. Cordon Cardo, H. S. Zhang et al., “Selection of carbohydrate tumour antigens as targets for immune attack using immunohistochemistry. I. Focus on gangliosides,” International Journal of Cancer, vol. 73, pp. 42–49, 1997. View at Google Scholar
  10. A. Carr, A. Mullet, Z. Mazorra et al., “A mouse IgG monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors,” Hybridoma, vol. 19, no. 3, pp. 241–247, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Vazquez, M. Alfonso, B. Lanne et al., “Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid-containing gangliosides that also recognizes sulfated glycolipids,” Hybridoma, vol. 14, no. 6, pp. 551–556, 1995. View at Google Scholar · View at Scopus
  12. M. Osorio, E. Gracia, E. Rodríguez et al., “Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a phase Ib/IIa study,” Cancer Biology and Therapy, vol. 7, no. 4, pp. 488–495, 2008. View at Google Scholar · View at Scopus
  13. R. Blanco, E. Rengifo, M. Cedeno, Ch. E. Rengifo, D. F. Alonso, and A. Carr, “Immunoreactivity of the 14F7 Mab raised against N-glycolyl GM3 ganglioside in epithelial malignant tumors from digestive system,” ISRN Gastroenterology, vol. 2011, Article ID 645641, 8 pages, 2011. View at Publisher · View at Google Scholar
  14. H. van Cruijsen, M. Ruiz, P. van der Valk, T. D. de Gruijl, and G. Giaccone, “Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer,” BMC Cancer, vol. 9, article 180, 2009. View at Publisher · View at Google Scholar
  15. A. M. Scursoni, L. Galluzzo, S. Camarero et al., “Detection and characterization of N-glycolyated gangliosides in Wilms tumor by immunohistochemistry,” Pediatric and Developmental Pathology, vol. 13, no. 1, pp. 18–23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Kohla, E. Stockfleth, and R. Schauer, “Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin,” Neurochemical Research, vol. 27, no. 7-8, pp. 583–592, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. S. Paller, S. L. Arnsmeier, J. K. Robinson, and E. G. Bremer, “Alteration in keratinocyte ganglioside content in basal cell carcinomas,” Journal of Investigative Dermatology, vol. 98, no. 2, pp. 226–232, 1992. View at Google Scholar · View at Scopus
  18. M. Heidenheim, E. R. Hansen, and O. Baadsgaard, “CDw60, which identifies the acetylated form of GD3 gangliosides, is strongly expressed in human basal cell carcinoma,” British Journal of Dermatology, vol. 133, no. 3, pp. 392–397, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Fahr and R. Schauer, “Detection of sialic acids and gangliosides with special reference to 9-O-acetylated species in basaliomas and normal human skin,” Journal of Investigative Dermatology, vol. 116, no. 2, pp. 254–260, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Liu, J. McCarthy, and S. Ladisch, “Membrane ganglioside enrichment lowers the threshold for vascular endothelial cell angiogenic signaling,” Cancer Research, vol. 66, no. 21, pp. 10408–10414, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Kawai, A. Kato, H. Higashi, S. Kato, and M. Naiki, “Quantitative determination of N-glycolylneuraminic acid expression in human cancerous tissues and avian lymphoma cell lines as a tumor-associated sialic acid by gas chromatography-mass spectrometry,” Cancer Research, vol. 51, no. 4, pp. 1242–1246, 1991. View at Google Scholar · View at Scopus
  22. A. Irie, S. Koyamat, Y. Kozutsumi, T. Kawasaki, and A. Suzuki, “The molecular basis for the absence of N-glycolylneuraminic acid in humans,” Journal of Biological Chemistry, vol. 273, no. 25, pp. 15866–15871, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Marquina, H. Waki, L. E. Fernandez et al., “Gangliosides expressed in human breast cancer,” Cancer Research, vol. 56, no. 22, pp. 5165–5171, 1996. View at Google Scholar · View at Scopus
  24. P. Tangvoranuntakul, P. Gagneux, S. Diaz et al., “Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 21, pp. 12045–12050, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Bardor, D. H. Nguyen, S. Diaz, and A. Varki, “Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells,” Journal of Biological Chemistry, vol. 280, no. 6, pp. 4228–4237, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. N. Malykh, R. Schauer, and L. Shaw, “N-glycolylneuraminic acid in human tumours,” Biochimie, vol. 83, no. 7, pp. 623–634, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Saida, S. Ikegawa, Y. Takizawa, and S. Kawachi, “Immunohistochemical detection of heterophile Hanganutziu-Deicher antigen in human malignant melanoma,” Archives of Dermatological Research, vol. 282, no. 3, pp. 179–182, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Higashi, M. Naiki, S. Matuo, and K. Okouchi, “Antigen of ‘serum sickness’ type of heterophile antibodies in human sera: identification as gangliosides with N-glycolylneuraminic acid,” Biochemical and Biophysical Research Communications, vol. 79, no. 2, pp. 388–395, 1977. View at Google Scholar · View at Scopus
  29. H. Nakakuma, K. Horikawa, T. Kawaguchi et al., “Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions,” Japanese Journal of Clinical Oncology, vol. 22, no. 5, pp. 308–312, 1992. View at Google Scholar · View at Scopus
  30. J. T. Mullen, L. Feng, Y. Xing et al., “Invasive squamous cell carcinoma of the skin: defining a high-risk group,” Annals of Surgical Oncology, vol. 13, no. 7, pp. 902–909, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. M. Evans, S. Hahn, D. R. Pook et al., “Detection of hypoxia in human squamous cell carcinoma by EF5 binding,” Cancer Research, vol. 60, no. 7, pp. 2018–2024, 2000. View at Google Scholar · View at Scopus
  32. J. Yin, A. Hashimoto, M. Izawa et al., “Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells,” Cancer Research, vol. 66, no. 6, pp. 2937–2945, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Carubia, R. K. Yu, and L. J. Macala, “Gangliosides of normal and neoplastic human melanocytes,” Biochemical and Biophysical Research Communications, vol. 120, no. 2, pp. 500–504, 1984. View at Google Scholar · View at Scopus
  34. D. A. Cheresh, R. A. Reisfeld, and A. P. Varki, “O-acetylation of disialoganglioside GD3 by human melanoma cells creates a unique antigenic determinant,” Science, vol. 225, no. 4664, pp. 844–846, 1984. View at Google Scholar · View at Scopus
  35. W. G. Dippold, H. P. Dienes, and A. Knuth, “Immunohistochemical localization of ganglioside GD3 in human malignant melanoma, epithelial tumors, and normal tissues,” Cancer Research, vol. 45, no. 8, pp. 3699–3705, 1985. View at Google Scholar · View at Scopus
  36. T. Tsuchida, R. E. Saxton, and R. F. Irie, “Gangliosides of human melanoma: GM2 and tumorigenicity,” Journal of the National Cancer Institute, vol. 78, no. 1, pp. 55–60, 1987. View at Google Scholar · View at Scopus
  37. H. Nakarai, P. J. Chandler, K. Kano, D. L. Morton, and R. F. Irie, “Hanganutziu-Deicher antigen as a possible target for immunotherapy of melanoma,” International Archives of Allergy and Applied Immunology, vol. 91, no. 3, pp. 323–328, 1990. View at Google Scholar · View at Scopus
  38. M. Alfonso, A. Díaz, A. M. Hernández et al., “An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients,” Journal of Immunology, vol. 168, no. 5, pp. 2523–2529, 2002. View at Google Scholar · View at Scopus
  39. S. Kawachi and T. Saida, “Analysis of the expression of Hanganutziu-Deicher (HD) antigen in human malignant melanoma,” Journal of Dermatology, vol. 19, no. 11, pp. 827–830, 1992. View at Google Scholar · View at Scopus
  40. H. E. Boddé, B. Holman, F. Spies et al., “Freeze-fracture electron microscopy of in vitro reconstructed human epidermis,” Journal of Investigative Dermatology, vol. 95, no. 1, pp. 108–116, 1990. View at Google Scholar · View at Scopus